Financing Vaccines for Global Health Security
Vu, J.; Kaplan, B.; Chaudhuri, S.; Mansoura, M.; Lo, A.
Show abstract
Recent outbreaks of infectious pathogens such as Zika, Ebola, and COVID-19 have underscored the need for the dependable availability of vaccines against emerging infectious diseases (EIDs). The cost and risk of R&D programs and uniquely unpredictable demand for EID vaccines have discouraged vaccine developers, and government and nonprofit agencies have been unable to provide timely or sufficient incentives for their development and sustained supply. We analyze the economic returns of a portfolio of EID vaccine assets, and find that under realistic financing assumptions, the expected returns are significantly negative, implying that the private sector is unlikely to address this need without public-sector intervention. We have sized the financing deficit for this portfolio and propose several potential solutions, including price increases, enhanced public-private partnerships, and subscription models through which individuals would pay annual fees to obtain access to a portfolio of vaccines in the event of an outbreak.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: a mathematical modelling analysis 94%
- Projected COVID-19 epidemic in the United States in the context of the effectiveness of a potential vaccine and implications for social distancing and face mask use 93%
- Predicting immune protection against outcomes of infectious disease from population-level effectiveness data with application to COVID-19 93%
Similar papers in this journal
- The health and economic repercussions of declining MMR coverage in the United States 94%
- Dynamic Prioritization of COVID-19 Vaccines When Social Distancing is Limited for Essential Workers 93%
- Economic evaluation of disease elimination: an extension to the net benefits framework and application to human African trypanosomiasis 92%
Similar papers in this journal
Similar papers in this journal
- Projecting the impact of SARS-CoV-2 variants on the COVID-19 epidemic and social restoration in the United States: a mathematical modelling study 92%
- Assessing COVID-19 vaccination strategies in varied demographics using an individual-based model 90%
- Model-based impact evaluation of new tuberculosis vaccines in aging populations under different modeling scenarios: the case of China. 90%
Similar papers in this journal
- National interest may require distributing COVID-19 vaccines to other countries 95%
- COVID-19 vaccines that reduce symptoms but do not block infection need higher coverage and faster rollout to achieve population impact 94%
- A phased lift of control: a practical strategy to achieve herd immunity against Covid-19 at the country level 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.